The purpose of this study is to compare the safety and efficacy of twice daily subantimicrobial dose doxycycline 20mg with daily doxycycline 100mg in treatment of mild and moderate Acne...
Date First Received: October 16, 2006
Last Updated: January 22, 2008
Verified by: Shaheed Beheshti Medical University, January 2008
Clinical Trial Phase: Phase 2/Phase 3 | Start Date: October 2005
Overall Status: Recruiting
Estimated Enrollment: 100
Brief Summary
Official Title: “The Effect of Doxycycline 100mg and Doxycycline 20mg in Treatment of Mild and Moderate Acne”
Condition Keyword(s):
Intervention(s):
The purpose of this study is to compare the safety and efficacy of twice daily subantimicrobial dose doxycycline 20mg with daily doxycycline 100mg in treatment of mild and moderate Acne.
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Dose Comparison, Parallel Assignment, Safety/Efficacy Study
Intervention(s) in this Clinical Trial
- Drug: Doxycycline
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- Acne
Exclusion Criteria:
- Pregnancy
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 18 Years
Maximum Age for this Clinical Trial: 40 Years
Are Healthy Volunteers Accepted for this Clinical Trial?: Accepts Healthy Volunteers
Clinical Trial Sponsor Information
Lead Sponsor: Shaheed Beheshti Medical University
Overall Clinical Trial Officials and Contacts
Parviz Toossi, M.D. Principal Investigator Shaheed Beheshti Medical University
Overall Contact: Parviz Toossi, M.D. 98-21-22744392 src@sbmu.ac.ir
Additional Information
Information obtained from ClinicalTrials.gov on September 05, 2008
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00388778
Study ID Number: src-pts-964
ClinicalTrials.gov Identifier: NCT00388778
Health Authority: Iran: Ethics Committee
Clinical Trials Authorship and Review
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
